Top of page
Lawyers

Ethan R. Goldman

Lawyers

Filters

All practices...
Antitrust & Competition
M&A-Related Antitrust
Capital Markets
Convertible & Hybrid Securities
Equity: Post-IPO
High-Yield Debt
Investment-Grade Debt
IPOs & Direct Listings
Corporate
Derivatives & Structured Products
Environmental
ESG Risk
Executive Compensation
Finance
DIP & Exit Finance
Direct Lending
Hybrid & Structured Capital
Leveraged Finance
Project & Infrastructure Finance
Financial Institutions
AML, Sanctions & CFIUS
Cryptocurrency & Digital Assets
Financial Institutions Capital Markets
Financial Institutions M&A
Financial Services Regulation & Enforcement
Investment Management
IP & Commercial Transactions
Liability Management & Special Opportunities
Litigation
Mergers & Acquisitions
Private Equity
Public Company Advisory
Real Estate
Restructuring
Bankruptcy Litigation
Company-Side Restructuring Matters
Creditor & Ad Hoc Group Restructuring Matters
Distressed M&A
Sponsor Finance
Tax
Tax Controversy
Transactional Tax Advice
All industries...
Cleantech
Consumer Products & Retail
Energy, Power & Infrastructure
Fintech & Cryptocurrency
Healthcare & Life Sciences
Industrials
Sports
Tech, Media & Telecom
Transportation & Logistics
All regions...
Asia
China
Europe
Latin America
Israel
JHSF Participações R$433 million equity offering
Davis Polk advised JHSF Participações S.A. in connection with the equity offering by JHSF Participações and a selling shareholder of 44,427,950 common shares for an aggregate amount of R…
Abbott Laboratories $1.3 billion notes offering
Davis Polk advised the joint book-running managers on an SEC-registered offering by Abbott Laboratories of $650 million aggregate principal amount of 1.150% notes due 2028 and $650…
Aviation Capital Group cash tender offer
Davis Polk advised the dealer manager in connection with a cash tender offer by Aviation Capital Group LLC to purchase any and all of its outstanding 7.125% notes due 2020. Aviation…
ChemoCentryx $346.8 million follow-on offering
Davis Polk advised the representatives of the several underwriters in connection with the SEC-registered offering of 5,980,000 shares of common stock of ChemoCentryx, Inc. (which…
BankUnited $300 million notes offering
Davis Polk advised the underwriters on an SEC-registered offering by BankUnited, Inc. of $300 million aggregate principal amount of 5.125% subordinated notes due 2030.BankUnited, Inc…
Warner Music Group $1.925 billion IPO
Davis Polk advised the representatives of the several underwriters, in connection with the $1.925 billion initial public offering of 77,000,000 shares of Class A common stock of Warner…
Back to top